W
William E. Kraus
Researcher at Duke University
Publications - 625
Citations - 40583
William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: protocol for personalized medicine effectiveness study in air force primary care.
Allison Vorderstrasse,Geoffrey S. Ginsburg,William E. Kraus,Maj Carlos J. Maldonado,Ruth Q. Wolever +4 more
TL;DR: Novel strategies deployed within existing AF primary care to increase adherence to evidence-based diet, physical activity, smoking cessation, and medication recommendations for CHD and T2D risk reduction through methods of patient engagement and self-management support are tested.
Journal ArticleDOI
The US Physical Activity Guidelines Advisory Committee Report-Introduction.
TL;DR: A range of health outcomes for which regular moderate-to-vigorous intensity physical activity plays an important mitigating or beneficial role are confirmed, and substantial growth in the scope, depth, and breadth of the physical activity and health literature is seen.
Journal ArticleDOI
Relations of a Marker of Endothelial Activation (s-VCAM) to Function and Mortality in Community-Dwelling Older Adults
Kim M. Huffman,Carl F. Pieper,Virginia B. Kraus,William E. Kraus,Gerda G. Fillenbaum,Harvey J. Cohen +5 more
TL;DR: Independent of inflammation and coagulation markers, endothelial dysfunction serves as a marker of, and potentially contributes causally to, poor function and death in community-dwelling older adults.
Journal ArticleDOI
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial).
Shelby D. Reed,Yanhong Li,Mark E. Dunlap,William E. Kraus,Gregory P. Samsa,Kevin A. Schulman,Michael R. Zile,David J. Whellan +7 more
TL;DR: Resource use and associated medical costs in the last year of life differed markedly in patients with HF who experienced SCD and patients who died of other causes, suggesting that cost-effectiveness analyses of interventions that reduce mortality from SCD compared to other causes should incorporate mode-specific end-of-life costs.
Journal ArticleDOI
The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action
TL;DR: Improved understanding of these mechanisms will lead to better understanding of the clinical implications of a healthy lifestyle and may ultimately offer new therapeutic targets for common medical conditions such as insulin resistance and diabetes.